Antibodies against advanced glycation end products in patients with type 1 diabetes mellitus;Autoanticuerpos dirigidos contra productos de glicación avanzada en pacientes con diabetes mellitus tipo 1

Revista Medica de Chile

Volumn 129, Issue 2, 2001, Pages 141-148

  González R, Margarita ^a   Paquién M, Christine ^b   Asenjo M, Sylvia ^b   Gleisner E, Andrea ^b   Kirsten L, Lilian ^b   Bustamante C, Marcelo ^b  

^a UNIVERSITY OF CONCEPCIÓN   (Chile)

^b NONE

Author keywords

Antibodies; Diabetes mellitus; Glycosylation and products; Insulin dependent

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AUTOANTIBODY; PROTEIN;

ADOLESCENT; ARTICLE; BLOOD; CASE CONTROL STUDY; CHILD; HUMAN; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; METABOLISM; PRESCHOOL CHILD;

ADOLESCENT; AUTOANTIBODIES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; PROTEINS;

EID: 0035259349     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. BIERHAUS A, HOFMAN MA, ZIEGLER R, NAWROTH PP. ages and their interaction with AGE-receptors in vascular disease and diabetes mellitus. The AGE concept. Cardiovascular Res 1998; 37: 586-600
2. LYONS TJ, PATRICK JS, BAYNES JW, CALWELL JA, LOPES-VIRELLA MF. Glycosilation of low density lipoprotein in patients with type I diabetes. Correlation with other parameters of glycaemic control. Diabetologia 1986; 29: 685-9.
3. FU MX, WELLS-KNECHT KJ, BLACKLEDGE JA, LYONS TJ, THORPE SR, BAYNES JW. Glycation, glycoxidation and cross-linking of collagen by glucose. Diabetes 1994; 43: 676-83.
4. MAKITA Z, YANAGISAGUA K, KUWAJIMA S, YOSHIKA N, ATSUMI T, HASUNUMA Y ET AL. Advanced glycation endproducts and diabetes nephropathy. J Diabetes Complications 1995; 9: 265-8.
5. ZHANG H, YANG Y, STEINBRECHER P. Structural requirements for the binding of modified proteins to the scavenger receptor of macrophages. J Biol Chem 1993; 268: 5535-42.
6. WICK G, SCHETT G, AMBERGER A, KLEINDIENST R, XU Q. Is atherosclerosis an immunologically mediated disease? I Today 1995; 16: 27-33.
7. VLASSARA H. Receptor-mediated interactions of advanced glycosylation end products with cellular components within diabetic tissues. Diabetes 1992; 41 (suppl 2): 52-6.
8. VLASSARA H, BROWNLEE M, CERAMI A. Accumulation of diabetic rat peripheral nerve mielin by macrophages increases with the presence of advanced glycosylation end products. J Exp Med 1984; 160: 197-207.
9. YAN SD, MAKITA Z, HORII Y, BRUNELLE S, CERAMI A, SEHAJPAL P ET AL. Two novel rat liver membrane proteins that bind advanced glycosylation end products: Relationship to macrophage receptor for glucose-modified proteins. J Exp Med 1991; 174: 515-24.
10. LOPES-VIRELLA MF, VIRELLA G. Immune mechanism for atherosclerosis in diabetes mellitus. Diabetes 1992; 41: 86-91.
11. VLASSARA H, BROWLEE M, CERAMI A. high -affinity-receptor-mediated uptake and degradation of glucose-modified proteins: a potential mechanism for the removal of senescent macromolecules. Proc Natl Acad Sci USA 1985; 82: 5588-92.
12. SHUMAKER VN, PUPPIONE DL. Sequential Flotation Ultracentrifugation. In: Methods in Enzymol 1986; 128: 155-69.
13. BUCALA R, MAKITA Z, VEGA G, SCOTT G, KOSHINSKY T, CERAMI A ET AL. Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency. Proc Natl Acad Sci USA 1994; 91: 9441-5.
14. OBAYASHI H, NAKANO K, SHIGETA H, YAMAGUSHI M, YOSHIMORI K, FUKUI M ET AL. Formation of cross-line as a fluorescent advanced glycation end products in vitro and in vivo. Biochem Biophys Res Comm 1996; 226: 37-41.
15. CRAIG WY, DAVIS AE, POULIN SE. Effects of incubation conditions on Elisa for autoantibodies against oxidized low density lipoproteins. Clin Chem 1996; 42: 1709-11.
16. WATANABE J, WOHLTMANN HJ, KLEIN RL, COLWELL JA, LOPES-VIRELLA MF. Enhancement of platelet aggregation of low density lipoprotein from IDDM patients. Diabetes 1988; 37: 1652-7.
17. PALINSKI W, KOSHINSKY T, BUTLER SW, MILLER E, VLASSARA H, CERAMI A ET AL. Immunochemical evidence for the presence of advanced glycosylation end products in atherosclerotic lesion of euglicemic rabbits. Atheroscler Thromb Vasc Biol 1995; 15: 571-82.
18. CALVO C, BUSTOS P, GIRAUDO P, ULLOA N, SEPÚLVEDA J, VERDUGO C ET AL. A Monoclonal Antibody-based Enzyme Immunoassay for the Measurement of Native and Glycated Apolipo-protein B-containing Particles. J Atheroscler Thromb 1997; 4: 57-61.
19. POPOV D, HASU M, COSTACHE G, STERN D, SIMIONESCU M. Capillary and aortic endothelia interact in situ with non enzimatically glycated albumin and develop specific alterations in early experimental diabetes. Acta Diabetol 1997; 34: 285-93.
20. LIGGINS J, FURTH A. Role of protein-bound carbonyl groups in the formation of advanced glycation end products. Biochem Biophys Acta 1997; 1361: 123-30.
21. BERG TJ, DAHL-JORGENSEN K, TORJENSEN PA, HANSSEN KF. Increased serum levels of advanced glycation end products (AGEs) in children and adolescent with IDDM. Diabetes Care 1997; 20: 1006-8.
22. MENZEL J, FESTA A, KOPP HP, SCHERNTHANER G. Increased levels of autoantibodies against advanced glycosylation end products in type 1 Diabetes mellitus. Diabetologia 1995; 38 (supp 1): 161.
23. POPOV D, HASU M, COSTACHE G, STERN D, SIMIONESCU M. Capillary and aortic endothelia interact in situ with non enzimatically glycated albumin and develop specific alterations in early experimental diabetes. Acta Diabetol 1997; 34: 285-93.
24. AHMED E, NITYANAND S, MUTAFA A, BRISMAR K, LEFVERT AK. Anti-cardiolipin antibodies and circulating immune complexes in type 1 diabetes mellitus: increased prevalence and relation to vascular complications. Clin Exp Immunol 1999; 115: 255-9.
25. MIRONOVA M, VIRELLA G, VIRELLA-LOWELL I, LOPES-VIRELLA M. Anti-modified LDL antibodies and LDL-containing Immune Complexes in IDDM Patients and Healthy Controls. Clin Immunol Immunopathol 1997; 85: 73-82.
26. GISSINGER C, VIRELLA GT, LOPES-VIRELLA MF. Erythrocyte-bound LDL immune complexes lead to cholesteryl ester accumulation in human macrophages. Clin Immunol Immunopathol 1991; 59: 37-51.
27. BUCALA R, MAKITA Z, KOSCHINSKY T, CERAMI A, VLASSARA H. Lipid advanced glycosilation:pathway for lipid oxidation in vivo. Proc Natl Acad Sci USA 1993; 90: 6434-8.